U19 Influenza Immunity: Protective Mechanisms Against a Pandemic Respiratory Virus. Project 1: B-cell Immunity to Influenza. Technical Development Project 1: Measuring the Immunome: Genomic Approaches to B-cell Repertoire- Year 1, 2009

NCT02133781 Phase 4 COMPLETED Results posted

This is an exploratory study using a strategy that has not been previously employed to investigate the effects of age and vaccine type on specific kinds of immune responses to licensed, seasonal 2009-2010 influenza vaccines in children and adults.

Details

Lead sponsor	Stanford University
Phase	Phase 4
Status	COMPLETED
Enrolment	51
Start date	2009-07
Completion	2009-12

Conditions

• Influenza

Interventions

• Fluzone® 2009-2010 Formula
• FluMist® 2009-2010 Formula

Primary outcomes

• Number of Participants From Each Arm Who Received Influenza Vaccine — Day 0 to 28

Countries

United States